What's fueling the opioid epidemic, and how can it be stopped?

December 6, 2017 by Fariss Samarrai, University of Virginia
Credit: University of Virginia

Richard Bonnie, a University of Virginia professor of public policy, law and medicine, this year chaired a National Academies of Science study that provided recommendations for addressing the national opioid crisis. The committee, formed at the request of the Food and Drug Administration, was composed of national experts in public health and pain management.

Bonnie, who directs UVA's Institute of Law, Psychiatry and Public Policy, recently took some time to discuss the panel's findings.

Q. Millions of people in the U.S. are addicted to opioids, and drug overdoses are the leading cause of unintentional death. What is the scope of the problem?

A. The U.S. has had a problem with opioid addiction for a very long time, since the development of morphine as a painkiller in the 19th century. Then heroin was developed as a non-addictive synthetic that also proved to be highly addictive, and we have had an endemic heroin problem for many decades.

The recent opioid epidemic has been associated with new opioid formulations approved by the FDA in the 1990s. Unfortunately, what we are seeing now is unprecedented. At least 2 million people are addicted to prescription medications. At least another 600,000 are addicted to heroin.

Q. How did this happen?

A. Tens of millions of Americans suffer from and the new generation of opioid medications have been aggressively promoted and widely prescribed. Although they were initially said to be non-addictive, those claims were false.

In retrospect, the growth of this epidemic resulted from a health system failure – by the manufacturers, FDA, the medical schools, professional organizations and state regulatory authorities.

We know that there are some underlying vulnerabilities involving poverty, emotional distress, social demoralization, as well as poor access to quality health care. The Great Recession several years ago accentuated the overall problem, when people lost jobs and hope in many communities, particularly in rural areas, Rust Belt cities and Appalachia. The repercussions have continued in distressed areas where economic recovery has been slow.

Once people are addicted, they often seek illicit alternatives when they no longer can obtain prescriptions from their doctors. Often this leads to overdose and death.

The crisis, by the way, has penetrated all sectors of society, and affects all of us.

Q. What can be done to solve this problem?

A. Awareness of the extreme seriousness of this problem, and resolve to solve it over the long haul is key. It took decades for the epidemic to develop, and it will take many years to unwind.

We need to better educate the public and the health care community of the risk factors of opioids, and offer alternatives for pain treatment. Physicians must shift patients away from opioids for pain management, health insurers need to reimburse for effective non-pharmacological treatments for chronic pain, and we must accelerate research to develop non-addictive analgesics. Making medically assisted treatments available to people with addiction is imperative, and would move many away from the illicit markets. Medicaid expansion is essential.

Also, medical education must pay more attention to so our future doctors have a much better understanding of pain and addiction, and can better coordinate treatment plans.

We also need a broader regulatory approach to drugs currently on the market, and better monitoring of the prescribing of these drugs.

If we take these steps – investing in research, training and proper treatment – and sustain the effort, we can greatly reduce the problem of addiction for the well-being of all of society.

Explore further: Study suggests ending opioid epidemic will take years

Related Stories

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Plastic surgeons get tips on managing opioid addiction risk

October 2, 2017
Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery, the official ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

Opioid crisis cost $504B in 2015, higher than once thought

November 20, 2017
President Donald Trump said Monday that the opioid epidemic is "ravaging so many American families and communities." It also appears to be more expensive than previously thought, according to a government analysis released ...

Opioid misuse is increasing in middle-aged Britons – here's how it could cause an addiction crisis

July 31, 2017
The older we get, the more likely we are to suffer with long-term health problems. Life expectancy may be increasing, but so are the number of years we spend in ill health. In people aged 50 and over, the leading causes of ...

Treating acute pain in opioid-dependent patients: Review and recommendations

September 13, 2017
As healthcare providers see more patients with opioid abuse and dependence, they face a difficult challenge: What's the best way to manage acute pain without contributing to the patient's opioid use disorder (OUD)? A review ...

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.